Athersys to start new clinical trial

Story excerpt provided by Crain’s Cleveland Business.

Written by Chuck Soder.

Athersys plans to begin a new clinical trial with the help of a grant from Innovate UK, a public organization that aims to promote innovation in England.

The Cleveland-based stem cell therapy company will receive up to 2 million British pounds (about $3 million) to start a phase 2a trial that would test whether its MultiStem therapy could help patients with acute respiratory distress syndrome.

Click here to read the complete article.

Originally published January 22, 2015.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: